Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Effectiveness of Steroid Injections vs. Placebo Evaluated for Knee Pain

Catherine Kolonko  |  Issue: September 2017  |  September 17, 2017

Seasontime / shutterstock.com

Seasontime / shutterstock.com

A two-year study among patients with knee osteoarthritis (OA) showed that steroid injections for knee pain were no more effective than saline injections and actually reduced cartilage volume more than placebo. The study, conducted at Tufts Medical Center in Boston, looked at progression of cartilage loss and change in knee pain after treatment with placebo or intra-articular injection of 40 mg triamcinolone acetonide every three months for two years. Results were published in JAMA.1

Background

Knee OA is a widespread condition that affects millions of mostly older people and is a leading cause of disability, according to the JAMA article. For years, doctors have been using corticosteroids to temporarily treat pain resulting from knee OA, with debatable success.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

“Osteoarthritis is a very common disease, and there isn’t any treatment that’s really been shown to be effective over the long term,” lead study author Timothy E. McAlindon, MD, MPH, chief of rheumatology at Tufts Medical Center, tells The Rheumatologist. “In particular, we don’t have any treatments that are generally believed to be disease modified.”

Pain in the knee is caused by inflammation that can happen when protective cartilage in the joints wears down and bones rub together. Patients with the condition often have difficulty with weight-bearing physical movement, such as standing up, walking, running or various forms of exercise.

Dr. McAlindon

Dr. McAlindon

Rheumatologists have a toolbox of treatments for knee joint pain, such as physical therapy, orthotics, topical medication, simple analgesics and even surgery, if deemed suitable. Yet a subset of patients return regularly every three months to have their knees injected with steroids because they have no other suitable treatment choice, Dr. McAlindon says.

Steroids also may be used for patients who have reflux or peptic ulcer or kidney disease because anti-inflammatory medicine is contraindicated. In cases like these, rheumatologists may resort to giving repeated steroid injections, Dr. McAlindon says.

No doubt, patients have benefited from short-term steroid injections to treat flare-up pain that lasts two to four weeks, Dr. McAlindon says. However, historically there has been concern about potential damage to joints, based partly on animal studies that suggested steroids can damage healthy cartilage, according to Dr. McAlindon.

On the other hand, inflammation exists in osteoarthritic joints, notes Dr. McAlindon. “Of course, steroids are potent anti-inflammatory agents, and more recent animal studies suggest that steroids may actually slow down disease progression.”

Inflammation is a common ailment among patients with progressive knee OA. Corticosteroids injected into the joint area can reduce cartilage damage associated with synovitis—inflammation of the membrane that lines the joints—but carry a possibility of adverse effects on cartilage periarticular bone, according to the JAMA article.

Page: 1 2 3 | Single Page
Share: 

Filed under:ConditionsOsteoarthritis and Bone DisordersResearch Rheum Tagged with:cartilage lossClinicalJAMAknee osteoarthritisknee painoutcomeplaceboResearchRheumatic Diseaserheumatologyrisksalinesteroid injectiontriamcinolone acetonide

Related Articles

    Basics of Biologic Joint Reconstruction

    April 6, 2012

    For young patients especially, this can delay knee replacement and provide better outcomes.

    2015 ACR/ARHP Annual Meeting: Stroke Risk Elevated after Herpes Zoster Infection Among Patients with Autoimmune Disease

    February 16, 2016

    SAN FRANCISCO—The risk of stroke after herpes zoster (HZ) infection is elevated in the period immediately after infection in patients with autoimmune diseases, according to a study presented at the 2015 ACR/ARHP Annual Meeting.1 The findings were presented in a scientific session, called Discover 2015, that highlighted new research. In another study from the session,…

    Post-Traumatic Osteoarthritis: Managing OA That Develops After Joint Injuries & Reconstructive Surgery

    November 28, 2018

    CHICAGO—Joint trauma is one of many potential drivers of osteoarthritis disease activity and structural progression. In Post-Traumatic OA: Pathogenesis, Clinical Evolution and Management, a session at the 2018 ACR/ARHP Annual Meeting, experts discussed the effects of sports and other injuries on even young patients’ joints. Post-traumatic osteoarthritis (OA) may account for 12% of hip, knee…

    New Therapeutics for Osteoarthritis May Be in Sight

    April 1, 2015

    Overview of OA pathogenesis, recent discoveries suggest new treatment strategies are possible

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences